Trials / Conditions / MDS-EB
MDS-EB
3 registered clinical trials studyying MDS-EB.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Allogenic NK Cell Transfusion Azacitidine MDS-EB NCT04599426 | The Second Hospital of Shandong University | Phase 1 / Phase 2 |
| Terminated | A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML NCT05933070 | Inmune Bio, Inc. | Phase 1 |
| Unknown | Low-dose AZA Combined With Short Term CAG Derived Regimen as a Bridging Treatment in Patients With Advanced MD NCT04216355 | Fujian Medical University | Phase 2 / Phase 3 |